TOVX

Theriva Biologics, Inc.

Healthcare · Biotechnology

$102.71 sample

+0.08 (+0.08%) 1D

Market cap

$139.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-30

Alerts

8

Price$102.71 +0.10% 3M daily closessample

106.81100.32

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider buy: Chief Financial Officer
Oct 05INSInsider sell: 10% owner
Sep 30SEC8-K filed: material event
Sep 25INSInsider sell: Chief Financial Officer
Sep 18INSInsider sell: General Counsel
Sep 10SECDEF 14A filed
Sep 01SEC10-Q filed
Aug 21INSInsider sell: 10% owner

Sign up to see the real TOVX record →

Company facts

SEC EDGAR registration

Name: Theriva Biologics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -19sample, -100 to +100
Reporting currency: USD

Who is positioning in TOVX

sample

Insiders: 6 insider transactions over 90 days, net selling, $493.6M
Congress: 2 members traded over 90 days
Institutions · 13F: 42 funds hold $1.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$5.7B +17.4% y/y

Q4 2024Q3 2026

Inventory$3.5B +8.7% y/y

Q4 2024Q3 2026

Accounts receivable$2.6B +15.2% y/y

Q4 2024Q3 2026

Total debt$7.3B +20.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $70.9B +10.7% 3M
Sample peer B: $89.2B -4.1% 3M
Sample peer C: $76.6B +3.3% 3M
Sample peer D: $28.9B -4.4% 3M
Sample peer E: $71.2B -9.1% 3M